Xiansheng Pharmaceutical (02096) announced that on April 16, 2024, the company spent HK$19611 million...
According to the Zhitong Finance App, Xiansheng Pharmaceutical (02096) announced that on April 16, 2024, the company spent HK$19.611 million to repurchase 3.81 million shares, with a repurchase price of HK$5.11-5.21 per share.